For US adult cancer survivors with a new alcohol use disorder diagnosis, the 1-year cumulative incidence of treatment initiation was 14.3%.

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders.

Nontraumatic subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disabilities in the world.

Patients with acute episodic migraine consistently prioritize pain relief over other treatment attributes such as route of administration, adverse outcomes, and costs, according to study results ...

For adult patients with transient ischemic attack/mild stroke, disturbed sleep is associated with greater cerebral small vessel disease burden and worse cognitive outcomes.

Central hypersomnolence disorders, such as narcolepsy type 2 and idiopathic hypersomnia, are associated with reduced health-related quality of life.

Higher adherence to the MIND diet in mid to late life is associated with a reduced risk for Alzheimer disease and related dementias.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

The Food and Drug Administration has granted Fast Track designation to ATH434 for the treatment of multiple system atrophy.

HealthDay News — Among U.S. youth, overdose deaths attributable to synthetic opioids alone are increasingly predominant, according to a study published online May 20 in Pediatrics.

Patients with Alzheimer disease and cognitive impairment with delayed REM sleep patterns have increased levels of brain amyloid and tau.

A scientific statement has been published by the American Heart Association regarding the effect of sleep health on cardiometabolic health.